{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:36:06Z","timestamp":1786653366020,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Bioall Sci"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0975-7406.160040","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T07:40:13Z","timestamp":1436168413000},"page":"239","source":"Crossref","is-referenced-by-count":59,"title":["Perspective: Does personalized medicine hold the future for medicine?"],"prefix":"10.4103","volume":"7","author":[{"given":"AkosuaAdom","family":"Agyeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ofori-Asenso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0975-7406.160040-1","unstructured":"Coca Cola. Share a Coke FAQs; 2010. Available from: http:\/\/www.coca-cola.co.uk\/faq\/products\/share-a-coke.html. [Last accessed on 2013 Aug 07]."},{"key":"key-10.4103\/0975-7406.160040-2","unstructured":"Pfizer. Personalised Medicine FAQ; 2013. Available from: http:\/\/www.pfizer.ie\/cancer_faq.cfm. [Last accessed on 2013 Aug 07]."},{"key":"key-10.4103\/0975-7406.160040-3","unstructured":"Pucheril D. The History and Future of Personalised Medicine; 2011. Available from: http:\/\/www.managedcaremag.com\/content\/history-and-future-personalized-medicine. [Last accessed on 2013 Aug 08]."},{"key":"key-10.4103\/0975-7406.160040-4","doi-asserted-by":"crossref","unstructured":"Jain KK. Textbook of Personalised Medicine. Netherlands: Springer Science+Business Media; 2009.","DOI":"10.1007\/978-1-4419-0769-1"},{"key":"key-10.4103\/0975-7406.160040-5","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1001\/jama.2013.6629","article-title":"Personalized medicine vs guideline-based medicine","author":"Goldberger","year":"2013","journal-title":"JAMA"},{"key":"key-10.4103\/0975-7406.160040-6","unstructured":"Usnewshealth. Personalised Medicine; 2011. Available from: http:\/\/www.health.usnews.com\/health-conditions\/cancer\/personalized-medicine. [Last accessed on 2013 Aug 08]."},{"key":"key-10.4103\/0975-7406.160040-7","unstructured":"NHGRI. Genome-Wide Association Studies; 2013. Available from: http:\/\/www.genome.gov\/20019523. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-8","first-page":"287","article-title":"Predicting the probable outcome of treatment in HCV patients","author":"Udayakumar","year":"2009","journal-title":"Therap Adv Gastroenterol"},{"key":"key-10.4103\/0975-7406.160040-9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.coph.2012.07.011","article-title":"Systems biology: Personalized medicine for the future?","author":"Chen","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"key-10.4103\/0975-7406.160040-10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/gm11","article-title":"Systems pharmacology and genome medicine: A future perspective","author":"Wist","year":"2009","journal-title":"Genome Med"},{"key":"key-10.4103\/0975-7406.160040-11","unstructured":"Kennedy R. Biomarkers and Personalised Medicine; 2013. Available from: http:\/\/www.ecmcnetwork.org.uk\/prod_consump\/groups\/cr_common\/@ecm\/@gen\/documents\/generalcontent\/cr_015976.pdf. [Last accessed on 2013 Aug 10]."},{"key":"key-10.4103\/0975-7406.160040-12","unstructured":"Feinstein Kean Healthcare. What is Personalized Medicine?; 2013. Available from: http:\/\/www.ageofpersonalizedmedicine.org\/what_is_personalized_medicine\/. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2012.02.041","article-title":"Redefining clinical trials: The age of personalized medicine","author":"Vaidyanathan","year":"2012","journal-title":"Cell"},{"key":"key-10.4103\/0975-7406.160040-14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-BFNx015701 screening for hypersensitivity to abacavir","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0975-7406.160040-15","unstructured":"PricewaterhouseCoopers. $232 Billion Personalized Medicine Market to Grow 11 Percent Annually, Says Pricewaterhouse Coopers; 2009. Available from: http:\/\/www.prnewswire.com\/news-releases\/232-billion-personalized-medicine-market-to- grow-11-percent-annually-says- pricewaterhousecoopers-78751072.html. [Last accessed on 2013 Aug 10]."},{"key":"key-10.4103\/0975-7406.160040-16","unstructured":"Personalised Medicine Coalition. Personalised Medicine: An Introduction; 2013. Available from: http:\/\/www.personalizedmedicinecoalition.org\/sites\/default\/files\/personalmed_backgrounder.pdf. [Last accessed on 2013 Aug 10]."},{"key":"key-10.4103\/0975-7406.160040-17","unstructured":"Prnewswire. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California; 2013. Available from: http:\/\/www.prnewswire.com\/news-releases\/genomas-expands-personalized-medicine-business-with-clinical-laboratory-licenses-in-new-york-florida-california-194824371.html. [Last accessed on 2013 Aug 10]."},{"key":"key-10.4103\/0975-7406.160040-18","unstructured":"West D. Enabling Personalized Medicine through Health Information Technology; 2011. Available from: http:\/\/www.brookings.edu\/~\/media\/research\/files\/papers\/2011\/1\/28%20personalized%20medicine%20west\/0128_personalized_medicine_west.pdf. [Last accessed 2013 on Aug 10]."},{"key":"key-10.4103\/0975-7406.160040-19","unstructured":"Personal Genome Poject. Volunteers from the General Public Working Together with Researchers to Advance Personal Genomics; 2013. Available from: http:\/\/www.personalgenomes.org\/. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1586\/erm.09.25","article-title":"Current molecular diagnostics of breast cancer and the potential incorporation of microRNA","author":"Zoon","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"key":"key-10.4103\/0975-7406.160040-21","unstructured":"Business Wire. The University of Cambridge, Cancer Research Technology, Cancer Research UK and Perlegen Sciences Collaborate to Analyze Thousands of DNA Samples from Breast Cancer Patients; 2005. Available from: http:\/\/www.businesswire.com\/news\/home\/20050215006276\/en\/University-Cambridge-Cancer-Research-Technology-Cancer- Research. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-22","unstructured":"Farlex. Perlegen Sciences to Analyze Genetics of Common Diseases in Postmenopausal Women; Collaboration With Women\u2032s Health Initiative Funded by the National Institutes of Health; 2005. Available from: http:\/\/www.businesswire.com\/news\/home\/20050630005199\/en\/Perlegen-Sciences-Analyze-Genetics-Common-Diseases-Postmenopausal#.VW2J50ZJUdU. [Last accessed on 2015 Jun 02]."},{"key":"key-10.4103\/0975-7406.160040-23","unstructured":"1000GENOMES. About the 1000 Genomes Project; 2012. Available from: http:\/\/www.1000genomes.org\/about. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-24","unstructured":"Genomeweb. Scripps, Navigenics, Affy, and Microsoft Launch Long-term Study on Behavioral Effects of Personal Genetic Testing; 2008. Available from: http:\/\/www.genomeweb.com\/sequencing\/scripps-navigenics-affy-and-microsoft-launch-long-term-study-behavioral-effects. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-25","unstructured":"GSPP. 2006. The Genomics and Personalized Medicine Act of 2006. Available from: http:\/\/www.depts.washington.edu\/genpol\/docs\/ObamaGSPP-1pg.pdf. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ctrv.2012.12.011","article-title":"Targeted therapy in metastatic colorectal cancer - An example of personalised medicine in action","author":"Heinemann","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"key-10.4103\/0975-7406.160040-27","unstructured":"Keiger D, De Pasquale S. Trials and Tribulation. John Hopkins Magazin. Maryland: John Hopkins University; 2002."},{"key":"key-10.4103\/0975-7406.160040-28","unstructured":"Ryon. Why Gene Patents Matter for Personalized Medicine. Meditations and Musings of a Young Cancer Researcher; 2013. Available from: http:\/\/www.ryongraf.com\/2013\/05\/why-gene-patents-matter-for-personalized-medicine\/. [Last accessed on 2015 Jun 02]."},{"key":"key-10.4103\/0975-7406.160040-29","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","author":"Franks","year":"2004","journal-title":"Lancet"},{"key":"key-10.4103\/0975-7406.160040-30","unstructured":"Lenehan P, Gliklich R, Worzel B, Freshley J. Rescuing Drugs Through Personalized Medicine. Cambridge, MA: Advanstar Publication; 2005."},{"key":"key-10.4103\/0975-7406.160040-31","unstructured":"Lehner B. New Pathways Towards Personalized Medicine; 2013. Available from: http:\/\/www.rocheinstitute.com\/Biotechnology_new_paths_toward_personalized_medicine\/V78.html. [Last accessed on 2013 Aug 09]."},{"key":"key-10.4103\/0975-7406.160040-32","unstructured":"Bonislawski A. Verisante This Year to Launch Point -of-Care Biomarker-Based Skin Cancer Test; 2011. Available from: http:\/\/www.genomeweb.com\/proteomics\/verisante-year-launch-point-care-biomarker-based-skin-cancer-test. [Last accessed on 2013 Aug 09]."}],"container-title":["Journal of Pharmacy And Bioallied Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:54Z","timestamp":1786649754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0975-7406.160040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["160040"],"URL":"https:\/\/doi.org\/10.4103\/0975-7406.160040","relation":{},"ISSN":["0975-7406"],"issn-type":[{"value":"0975-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}